Migdal Insurance & Financial Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-724
Closed -$48K 376
2025
Q4
$48K Buy
+724
New +$46.8K ﹤0.01% 281
2025
Q3
Sell
-519
Closed -$45K 342
2025
Q2
$45K Buy
+519
New +$40.7K ﹤0.01% 264
2024
Q3
Sell
-216
Closed -$25K 451
2024
Q2
$25K Buy
+216
New +$27.3K ﹤0.01% 344
2020
Q4
Sell
-13,968
Closed -$1.44M 670
2020
Q3
$1.44M Sell
13,968
-12,100
-46% -$1.26M 0.02% 233
2020
Q2
$2.64M Buy
26,068
+8,504
+48% +$761K 0.04% 161
2020
Q1
$1.18M Sell
17,564
-12,792
-42% -$796K 0.03% 152
2019
Q4
$1.66M Buy
30,356
+4,212
+16% +$200K 0.03% 156
2019
Q3
$975K Buy
26,144
+7,824
+43% +$304K 0.02% 249
2019
Q2
$686K Buy
18,320
+5,312
+41% +$167K 0.02% 289
2019
Q1
$387K Sell
13,008
-440
-3% -$15.5K 0.01% 333
2018
Q4
$403K Buy
+13,448
New +$427K 0.01% 289

Other funds holding DXCM

Migdal Insurance & Financial Holdings's DXCM Position: Q1 2026 in Review

Migdal Insurance & Financial Holdings sold out of DexCom (DXCM) in Q1 2026, closing a stake of 724 shares — an estimated $48K sold.

Migdal Insurance & Financial Holdings first reported a position in DXCM in Q4 2018 and held it in 11 quarters. The position peaked at $2.64M in Q2 2020. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Migdal Insurance & Financial Holdings reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 724 DexCom shares in Q1 2026, an estimated $48K.
  • Migdal Insurance & Financial Holdings first reported a position in DexCom in Q4 2018 and held it in 11 quarters.
  • Migdal Insurance & Financial Holdings's DexCom position peaked at $2.64M in Q2 2020.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2026, filed 14 May 2026.